Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.

Pöttgen J, Lau S, Penner I, Heesen C, Moritz S.

Int J MS Care. 2015 May-Jun;17(3):130-7. doi: 10.7224/1537-2073.2014-015.

2.

Case-Based fMRI Analysis after Cognitive Rehabilitation in MS: A Novel Approach.

Hubacher M, Kappos L, Weier K, Stöcklin M, Opwis K, Penner IK.

Front Neurol. 2015 Apr 8;6:78. doi: 10.3389/fneur.2015.00078. eCollection 2015.

3.

[Fatigue in patients with multiple sclerosis--pathogenesis, clinical picture, diagnosis and treatment].

Patejdl R, Penner IK, Noack TK, Zettl UK.

Fortschr Neurol Psychiatr. 2015 Apr;83(4):211-20. doi: 10.1055/s-0034-1399353. Epub 2015 Apr 20. German.

PMID:
25893494
4.

Cognitive rehabilitation of working memory in juvenile multiple sclerosis-effects on cognitive functioning, functional MRI and network related connectivity.

Hubacher M, DeLuca J, Weber P, Steinlin M, Kappos L, Opwis K, Penner IK.

Restor Neurol Neurosci. 2015 Apr 2. [Epub ahead of print]

PMID:
25835556
5.

Improvement in Fatigue during Natalizumab Treatment is Linked to Improvement in Depression and Day-Time Sleepiness.

Penner IK, Sivertsdotter EC, Celius EG, Fuchs S, Schreiber K, Berkö S, Svenningsson A; TYNERGY trial investigators.

Front Neurol. 2015 Feb 23;6:18. doi: 10.3389/fneur.2015.00018. eCollection 2015.

6.

Understanding intellectual enrichment: how cognitive reserve impacts on hippocampal volume in multiple sclerosis.

Muhlert N, Penner IK.

Eur J Neurol. 2015 Feb 12. doi: 10.1111/ene.12674. [Epub ahead of print] No abstract available.

PMID:
25683751
7.

Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis.

Rocca MA, Amato MP, De Stefano N, Enzinger C, Geurts JJ, Penner IK, Rovira A, Sumowski JF, Valsasina P, Filippi M; MAGNIMS Study Group.

Lancet Neurol. 2015 Mar;14(3):302-17. doi: 10.1016/S1474-4422(14)70250-9. Epub 2015 Feb 4. Review.

PMID:
25662900
8.

Towards the implementation of 'no evidence of disease activity' in multiple sclerosis treatment: the multiple sclerosis decision model.

Stangel M, Penner IK, Kallmann BA, Lukas C, Kieseier BC.

Ther Adv Neurol Disord. 2015 Jan;8(1):3-13. doi: 10.1177/1756285614560733.

9.

Layers of quasi-horizontally oriented ice crystals in cirrus clouds observed by a two-wavelength polarization lidar.

Borovoi A, Balin Y, Kokhanenko G, Penner I, Konoshonkin A, Kustova N.

Opt Express. 2014 Oct 6;22(20):24566-73. doi: 10.1364/OE.22.024566.

PMID:
25322032
10.

Defining the new end point for multiple sclerosis treatment.

Stangel M, Penner IK, Kieseier BC.

JAMA Neurol. 2014 Aug;71(8):1056-7. doi: 10.1001/jamaneurol.2014.1542. No abstract available.

PMID:
25111213
11.

Translational read-through as an alternative approach for ocular gene therapy of retinal dystrophies caused by in-frame nonsense mutations.

Nagel-Wolfrum K, Möller F, Penner I, Wolfrum U.

Vis Neurosci. 2014 Sep;31(4-5):309-16. doi: 10.1017/S0952523814000194. Epub 2014 Jun 10. Review.

PMID:
24912600
12.

Reduced magnetisation transfer ratio in cognitively impaired patients at the very early stage of multiple sclerosis: a prospective, multicenter, cross-sectional study.

Faiss JH, Dähne D, Baum K, Deppe R, Hoffmann F, Köhler W, Kunkel A, Lux A, Matzke M, Penner IK, Sailer M, Zettl UK.

BMJ Open. 2014 Apr 10;4(4):e004409. doi: 10.1136/bmjopen-2013-004409.

13.

Default mode network alterations during language task performance in children with benign epilepsy with centrotemporal spikes (BECTS).

Oser N, Hubacher M, Specht K, Datta AN, Weber P, Penner IK.

Epilepsy Behav. 2014 Apr;33:12-7. doi: 10.1016/j.yebeh.2014.01.008. Epub 2014 Feb 26.

PMID:
24583653
14.

Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.

Weier K, Penner IK, Magon S, Amann M, Naegelin Y, Andelova M, Derfuss T, Stippich C, Radue EW, Kappos L, Sprenger T.

PLoS One. 2014 Jan 22;9(1):e86916. doi: 10.1371/journal.pone.0086916. eCollection 2014.

15.

One step forward in the quest for evidence of the efficacy of cognitive rehabilitation in multiple sclerosis.

Penner IK, Sastre-Garriga J.

Mult Scler. 2014 Jan;20(1):2. doi: 10.1177/1352458513510982. No abstract available.

PMID:
24347477
16.

Working memory training in patients with chronic schizophrenia: a pilot study.

Hubacher M, Weiland M, Calabrese P, Stoppe G, Stöcklin M, Fischer-Barnicol D, Opwis K, Penner IK.

Psychiatry J. 2013;2013:154867. doi: 10.1155/2013/154867. Epub 2013 Feb 26.

17.

Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.

Achtnichts L, Gonen O, Rigotti DJ, Babb JS, Naegelin Y, Penner IK, Bendfeldt K, Hirsch J, Amann M, Kappos L, Gass A.

Eur J Radiol. 2013 Dec;82(12):e848-52. doi: 10.1016/j.ejrad.2013.08.037. Epub 2013 Sep 4.

18.

The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.

Yaldizli Ö, Penner IK, Frontzek K, Naegelin Y, Amann M, Papadopoulou A, Sprenger T, Kuhle J, Calabrese P, Radü EW, Kappos L, Gass A.

Mult Scler. 2014 Mar;20(3):356-64. doi: 10.1177/1352458513496880. Epub 2013 Aug 19.

PMID:
23959709
19.

Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.

Hofstetter L, Naegelin Y, Filli L, Kuster P, Traud S, Smieskova R, Mueller-Lenke N, Kappos L, Gass A, Sprenger T, Penner IK, Nichols TE, Vrenken H, Barkhof F, Polman C, Radue EW, Borgwardt SJ, Bendfeldt K.

Mult Scler. 2014 Feb;20(2):202-13. doi: 10.1177/1352458513493034. Epub 2013 Jun 26.

PMID:
23804554
20.

Natalizumab treatment reduces fatigue in multiple sclerosis. Results from the TYNERGY trial; a study in the real life setting.

Svenningsson A, Falk E, Celius EG, Fuchs S, Schreiber K, Berkö S, Sun J, Penner IK; Tynergy Trial Investigators.

PLoS One. 2013;8(3):e58643. doi: 10.1371/journal.pone.0058643. Epub 2013 Mar 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk